Vandetanib is an oral medication classified as a tyrosine kinase inhibitor (TKI). It is specifically designed to target and inhibit the activity of certain proteins involved in the growth and spread of cancer cells. By blocking these proteins, vandetanib can help to slow or stop the progression of certain types of cancer.
